Produção Nacional
Revisado por pares
Historical epidemiology of hepatitis C virus ( HCV ) in selected countries
2014; Wiley; Volume: 21; Issue: s1 Linguagem: Inglês
10.1111/jvh.12247
ISSN1365-2893
AutoresPhilip Bruggmann, Thomas Berg, Anne Øvrehus, Christophe Moreno, Carlos Eduardo Brandão‐Mello, Françoise Roudot‐Thoraval, Rui Tato Marinho, Morris Sherman, Stephen Ryder, Jan Šperl, Ulus Salih Akarca, İsmail Balık, Florian Bihl, Marc Bilodeau, Antonio Javier Blasco, Marı́a Buti, Filipe Calinas, José Luís Calleja, Hugo Cheinquer, Peer Brehm Christensen, Mette Rye Clausen, Henrique Sergio Coelho, Markus Cornberg, Matthew Cramp, Gregory J. Dore, Wahid Doss, Ann‐Sofi Duberg, Manal H. El‐Sayed, Gül Ergör, Gamal Esmat, Chris Estes, Karolin Falconer, J Félix, Maria Lúcia Gomes Ferraz, Paulo Roberto Abrão Ferreira, Soňa Fraňková, Javier García‐Samaniego, Jan Gerstoft, José Gíria, Fernando Lopes Gonçales, E. Gower, Michael Gschwantler, Mário G. Pessôa, Christophe Hézode, Heribert Hofer, Petr Husa, Ramazan İdilman, Martin Kåberg, K. Kaita, Achim Kautz, Sabahattin Kaymakoğlu, Mel Krajden, Henrik Krarup, Wim Laleman, Daniel Lavanchy, Pablo Lázaro, Paul Marotta, Stefan Mauss, Maria Cássia Mendes Corrêa, Beat Müllhaupt, Robert P. Myers, Francesco Negro, Vratislav Němeček, Necati Örmecı, Julie Parkes, Kevork Peltekian, Alnoor Ramji, Homie Razavi, Nathalia Rodrigues dos Reis, Stuart K. Roberts, William Rosenberg, Rui Sarmento‐Castro, C. Sarrazin, David Semela, Gamal Shiha, William Sievert, Peter Stärkel, Rudolf Stauber, A. Thompson, Petr Urbánek, Ingo van Thiel, Hans Van Vlierberghe, Dominique Vandijck, W. Vogel, Imam Waked, Heiner Wedemeyer, Nina Weis, Johannes Wiegand, A. Yosry, Amany Zekry, Pierre Van Damme, Soo Aleman, S. J. Hindman,
Tópico(s)Hepatitis B Virus Studies
ResumoSummary Chronic infection with hepatitis C virus (HCV) is a leading indicator for liver disease. New treatment options are becoming available, and there is a need to characterize the epidemiology and disease burden of HCV. Data for prevalence, viremia, genotype, diagnosis and treatment were obtained through literature searches and expert consensus for 16 countries. For some countries, data from centralized registries were used to estimate diagnosis and treatment rates. Data for the number of liver transplants and the proportion attributable to HCV were obtained from centralized databases. Viremic prevalence estimates varied widely between countries, ranging from 0.3% in Austria, England and Germany to 8.5% in Egypt. The largest viremic populations were in Egypt, with 6 358 000 cases in 2008 and Brazil with 2 106 000 cases in 2007. The age distribution of cases differed between countries. In most countries, prevalence rates were higher among males, reflecting higher rates of injection drug use. Diagnosis, treatment and transplant levels also differed considerably between countries. Reliable estimates characterizing HCV‐infected populations are critical for addressing HCV‐related morbidity and mortality. There is a need to quantify the burden of chronic HCV infection at the national level.
Referência(s)